A Case Study Application of the Aggregate Exposure Pathway (AEP) and Adverse Outcome Pathway (AOP) Frameworks to Facilitate the Integration of Human Health and Ecological End Points for Cumulative Risk Assessment (CRA)

被引:22
|
作者
Hines, David E. [1 ]
Edwards, Stephen W. [1 ]
Conolly, Rory B. [1 ]
Jarabek, Annie M. [2 ]
机构
[1] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27709 USA
[2] US EPA, Off Res & Dev, Natl Ctr Environm Assessment, Res Triangle Pk, NC 27709 USA
关键词
SODIUM-IODIDE SYMPORTER; AMMONIUM-PERCHLORATE; THYROID-FUNCTION; XENOPUS-LAEVIS; DOSE-RESPONSE; MECHANISM; TOXICITY; ECOTOXICOLOGY; METAMORPHOSIS; CONTAMINATION;
D O I
10.1021/acs.est.7b04940
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Cumulative risk assessment (CRA) methods promote the use of a conceptual site: model (CSM) to apportion exposures and integrate risk from multiple stressors. While CSMs may,encompass multiple species, evaluating end points across taxa can be challenging due to data availability and physiological differences among organisms. Adverse outcome pathways (AOPs) describe biological mechanisms leading to adverse outcomes (AOs) by assembling causal pathways with measurable intermediate steps termed key events (KEs), thereby providing a framework for integrating data across species. In this work, we used a case study focused on the perchlorate anion (ClO4-) to highlight the value of the AOP framework for cross-species data integration. Computational models and dose response data were used to evaluate the effects of ClO4- in 12 species and revealed a concordance across KEs and taxa. The aggregate exposure pathway (AEP) tracks stressors from sources to the exposures and serves as a complement to the AOP. We discuss how the combined AEP-AOP construct helps to maximize the use of existing data and advances CRA by (1) organizing toxicity and exposure data, (2) providing a mechanistic framework of KEs for integrating data across human health and ecological end points, (3) facilitating cross-species dose response evaluation, and (4) highlighting data gaps and technical limitations.
引用
收藏
页码:839 / 849
页数:11
相关论文
共 4 条
  • [1] Application of a combined aggregate exposure pathway and adverse outcome pathway (AEP-AOP) approach to inform a cumulative risk assessment: A case study with phthalates
    Clewell, Rebecca A.
    Leonard, Jeremy A.
    Nicolas, Chantel, I
    Campbell, Jerry L.
    Yoon, Miyoung
    Efremenko, Alina Y.
    McMullen, Patrick D.
    Andersen, Melvin E.
    Clewell, Harvey J., III
    Phillips, Katherine A.
    Tan, Yu-Mei
    TOXICOLOGY IN VITRO, 2020, 66
  • [2] A Quantitative Source-to-Outcome Case Study To Demonstrate the Integration of Human Health and Ecological End Points Using the Aggregate Exposure Pathway and Adverse Outcome Pathway Frameworks
    Hines, David E.
    Conolly, Rory B.
    Jarabek, Annie M.
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2019, 53 (18) : 11002 - 11012
  • [3] Leveraging human genetic and adverse outcome pathway (AOP) data to inform susceptibility in human health risk assessment
    Holly M. Mortensen
    John Chamberlin
    Bonnie Joubert
    Michelle Angrish
    Nisha Sipes
    Janice S. Lee
    Susan Y. Euling
    Mammalian Genome, 2018, 29 : 190 - 204
  • [4] Leveraging human genetic and adverse outcome pathway (AOP) data to inform susceptibility in human health risk assessment
    Mortensen, Holly M.
    Chamberlin, John
    Joubert, Bonnie
    Angrish, Michelle
    Sipes, Nisha
    Lee, Janice S.
    Euling, Susan Y.
    MAMMALIAN GENOME, 2018, 29 (1-2) : 190 - 204